J. Jennette and R. Falk, Small-Vessel Vasculitis, New England Journal of Medicine, vol.337, issue.21, pp.1512-1535, 1997.
DOI : 10.1056/NEJM199711203372106

N. Basu, R. Watts, I. Bajema, B. Baslund, T. Bley et al., EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis, Annals of the Rheumatic Diseases, vol.69, issue.10, pp.1744-50119032, 2009.
DOI : 10.1136/ard.2009.119032

N. Hu, J. Westra, and C. Kallenberg, Dysregulated neutrophil???endothelial interaction in antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitides: Implications for pathogenesis and disease intervention, Autoimmunity Reviews, vol.10, issue.9, pp.536-579, 2011.
DOI : 10.1016/j.autrev.2011.04.004

S. Lionaki, E. Blyth, S. Hogan, Y. Hu, B. Senior et al., Classification of antineutrophil cytoplasmic autoantibody vasculitides: The role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis, Arthritis & Rheumatism, vol.111, issue.10, pp.3452-62, 2012.
DOI : 10.1002/art.34562

C. Kallenberg, P. Heeringa, and C. Stegeman, Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides, Nature Clinical Practice Rheumatology, vol.26, issue.12, pp.661-70, 2006.
DOI : 10.1038/ncprheum0355

C. Stegeman, Anti-neutrophil cytoplasmic antibody (ANCA) levels directed against proteinase-3 and myeloperoxidase are helpful in predicting disease relapse in ANCA-associated small-vessel vasculitis, Nephrology Dialysis Transplantation, vol.17, issue.12, pp.2077-80, 2002.
DOI : 10.1093/ndt/17.12.2077

J. Finkielman, P. Merkel, D. Schroeder, G. Hoffman, R. Spiera et al., Antiproteinase 3 Antineutrophil Cytoplasmic Antibodies and Disease Activity in Wegener Granulomatosis, Annals of Internal Medicine, vol.147, issue.9, pp.611-620, 2007.
DOI : 10.7326/0003-4819-147-9-200711060-00005

B. Bottazzi, C. Garlanda, A. Cotena, F. Moalli, S. Jaillon et al., The long pentraxin PTX3 as a prototypic humoral pattern recognition receptor: interplay with cellular innate immunity, Immunological Reviews, vol.107, issue.1, pp.9-18, 2009.
DOI : 10.1111/j.1600-065X.2008.00719.x

B. Bottazzi, A. Doni, C. Garlanda, and A. Mantovani, An Integrated View of Humoral Innate Immunity: Pentraxins as a Paradigm, Annual Review of Immunology, vol.28, issue.1, pp.157-83, 2010.
DOI : 10.1146/annurev-immunol-030409-101305

F. Breviario, E. Aniello, J. Golay, G. Peri, B. Bottazzi et al., Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component

V. Alles, B. Bottazzi, G. Peri, J. Golay, M. Introna et al., Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes, Blood, vol.84, issue.10, pp.3483-93, 1994.

A. Nauta, S. De-haij, B. Bottazzi, A. Mantovani, M. Borrias et al., Human renal epithelial cells produce the long pentraxin PTX3, Kidney International, vol.67, issue.2, pp.543-53, 2005.
DOI : 10.1111/j.1523-1755.2005.67111.x

C. Garlanda, E. Hirsch, S. Bozza, A. Salustri, D. Acetis et al., Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response, Nature, vol.52, issue.6912, pp.182-188, 2002.
DOI : 10.1016/S0952-7915(97)80099-4

S. Jaillon, G. Peri, Y. Delneste, I. Fremaux, A. Doni et al., The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps, The Journal of Experimental Medicine, vol.65, issue.4, pp.793-804, 2007.
DOI : 10.1073/pnas.092112999

N. Borregaard and J. Cowland, Granules of the human neutrophilic polymorphonuclear leukocyte, Blood, vol.89, issue.10, pp.3503-3524, 1997.

V. Witko-sarsat, E. Cramer, C. Hieblot, J. Guichard, P. Nusbaum et al., Presence of proteinase 3 in secretory vesicles: evidence of a novel, highly mobilizable intracellular pool distinct from azurophil granules, Blood, vol.94, issue.7, pp.2487-96, 1999.

J. Augusto, C. Onno, S. Blanchard, S. Dubuquoi, A. Mantovani et al., Detection of anti-PTX3 autoantibodies in systemic lupus erythematosus, Rheumatology, vol.48, issue.4, pp.442-446, 2009.
DOI : 10.1093/rheumatology/ken507

N. Bassi, A. Ghirardello, M. Blank, S. Zampieri, P. Sarzi-puttini et al., IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus, Annals of the Rheumatic Diseases, vol.69, issue.9, pp.1704-10117804, 2009.
DOI : 10.1136/ard.2009.117804

R. Watts, S. Lane, T. Hanslik, T. Hauser, B. Hellmich et al., Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies, Annals of the Rheumatic Diseases, vol.66, issue.2, pp.222-229, 2007.
DOI : 10.1136/ard.2006.054593

B. Hellmich, O. Flossmann, W. Gross, P. Bacon, J. Cohen-tervaert et al., EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis, Annals of the Rheumatic Diseases, vol.66, issue.5, pp.605-622, 2007.
DOI : 10.1136/ard.2006.062711

B. Bottazzi, V. Vouret-craviari, A. Bastone, D. Gioia, L. Matteucci et al., Multimer Formation and Ligand Recognition by the Long Pentraxin PTX3: SIMILARITIES AND DIFFERENCES WITH THE SHORT PENTRAXINS C-REACTIVE PROTEIN AND SERUM AMYLOID P COMPONENT, Journal of Biological Chemistry, vol.272, issue.52, pp.32817-32840, 1997.
DOI : 10.1074/jbc.272.52.32817

G. Zandman-goddard, M. Blank, P. Langevitz, L. Slutsky, M. Pras et al., Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity, Annals of the Rheumatic Diseases, vol.64, issue.12, pp.1698-702, 2005.
DOI : 10.1136/ard.2005.035832

C. Sjowall, P. Eriksson, S. Almer, and T. Skogh, Autoantibodies to C-reactive Protein is a Common Finding in SLE, but not in Primary Sj??gren's Syndrome, Rheumatoid Arthritis or Inflammatory Bowel Disease, Journal of Autoimmunity, vol.19, issue.3, pp.155-60, 2002.
DOI : 10.1006/jaut.2002.0608

Y. Tan, F. Yu, Z. Qu, T. Su, G. Xing et al., Modified C-Reactive Protein Might be a Target Autoantigen of TINU Syndrome, Clinical Journal of the American Society of Nephrology, vol.6, issue.1, pp.93-100, 2011.
DOI : 10.2215/CJN.09051209

F. Fazzini, G. Peri, A. Doni, G. Dell-'antonio, E. Dal-cin et al., PTX3 in small-vessel vasculitides: An independent indicator of disease activity produced at sites of inflammation, Arthritis & Rheumatism, vol.43, issue.12, pp.2841-50, 2001.
DOI : 10.1002/1529-0131(200112)44:12<2841::AID-ART472>3.0.CO;2-6

M. Talor, J. Stone, J. Stebbing, J. Barin, N. Rose et al., Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA), Clinical & Experimental Immunology, vol.7, issue.1, pp.42-50, 2007.
DOI : 10.1111/j.1365-2249.2007.03453.x

A. Roth, J. Ooi, J. Hess, M. Van-timmeren, E. Berg et al., Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis, Journal of Clinical Investigation, vol.123, issue.4, pp.1773-83, 2013.
DOI : 10.1172/JCI65292DS1

R. Falk, R. Terrell, L. Charles, and J. Jennette, Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro., Proceedings of the National Academy of Sciences, vol.87, issue.11, pp.4115-4124, 1990.
DOI : 10.1073/pnas.87.11.4115

V. Witko-sarsat, M. Pederzoli-ribeil, E. Hirsch, S. Sozzani, and M. Cassatella, Regulating neutrophil apoptosis: new players enter the game, Trends in Immunology, vol.32, issue.3, pp.117-141, 2011.
DOI : 10.1016/j.it.2011.01.001

H. Xiao, P. Heeringa, P. Hu, Z. Liu, M. Zhao et al., Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice, Journal of Clinical Investigation, vol.110, issue.7, pp.955-63, 2002.
DOI : 10.1172/JCI0215918

R. Falk and J. Jennette, ANCA Disease: Where Is This Field Heading?, Journal of the American Society of Nephrology, vol.21, issue.5, pp.745-52, 2010.
DOI : 10.1681/ASN.2009121238

J. Gomez-puerta and X. Bosch, Anti-Neutrophil Cytoplasmic Antibody Pathogenesis in Small-Vessel Vasculitis, The American Journal of Pathology, vol.175, issue.5, pp.1790-1798, 2009.
DOI : 10.2353/ajpath.2009.090533

S. Jaillon, P. Jeannin, Y. Hamon, I. Fremaux, A. Doni et al., Endogenous PTX3 translocates at the membrane of late apoptotic human neutrophils and is involved in their engulfment by macrophages, Cell Death and Differentiation, vol.440, issue.3, pp.465-74173, 2008.
DOI : 10.1038/sj.cdd.4400826

J. Savill, I. Dransfield, C. Gregory, and C. Haslett, A blast from the past: clearance of apoptotic cells regulates immune responses, Nature Reviews Immunology, vol.22, issue.12, pp.965-75, 2002.
DOI : 10.1038/nri957

H. Gilligan, B. Bredy, H. Brady, M. Hebert, H. Slayter et al., Antineutrophil Cytoplasmic Autoantibodies Interact with Primary Granule Constituents on the Surface of Apoptotic Neutrophils in the Absence of Neutrophil Priming, Journal of Experimental Medicine, vol.184, issue.6, pp.2231-2272, 1996.
DOI : 10.1084/jem.184.6.2231

L. Harper, P. Cockwell, D. Adu, and C. Savage, Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis1, Kidney International, vol.59, issue.5, pp.1729-1767, 2001.
DOI : 10.1046/j.1523-1755.2001.0590051729.x

A. Van-rossum, H. Pas, F. Fazzini, M. Huitema, P. Limburg et al., Abundance of the long pentraxin PTX3 at sites of leukocytoclastic lesions in patients with small-vessel vasculitis, Arthritis & Rheumatism, vol.23, issue.3, pp.986-91, 2006.
DOI : 10.1002/art.21669

K. Kessenbrock, M. Krumbholz, U. Schonermarck, W. Back, W. Gross et al., Netting neutrophils in autoimmune small-vessel vasculitis, Nature Medicine, vol.416, issue.6, pp.623-628, 1959.
DOI : 10.1038/nm.1959

S. Sangaletti, C. Tripodo, C. Chiodoni, C. Guarnotta, B. Cappetti et al., Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity, Blood, vol.120, issue.15, pp.3007-3025, 2012.
DOI : 10.1182/blood-2012-03-416156

J. Knight and M. Kaplan, Lupus neutrophils, Current Opinion in Rheumatology, vol.24, issue.5, 2012.
DOI : 10.1097/BOR.0b013e3283546703